Comparison of contrast-enhanced ultrasonography and contrast-enhanced MRI for the assessment of vascularization of hydroxyapatite orbital implants

Clin Imaging. 2014 Sep-Oct;38(5):616-20. doi: 10.1016/j.clinimag.2014.05.005. Epub 2014 May 21.

Abstract

Objective: To compare contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging for the assessment of vascularization of hydroxyapatite orbital implants.

Methods: Ten patients who underwent monthly contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging following implantation were analyzed. The two modalities were compared according to their ability to visualize the progress of vascularization at monthly intervals.

Results: There were no differences in the findings shown by these two methods. Contrast-enhanced ultrasound provided better visualization of the dynamic process of vascularization than contrast-enhanced magnetic resonance imaging. There were no significant differences in the areas and the time to completion of fibrovascular ingrowth observed by contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging, indicating that the findings of these two examinations were consistently similar.

Conclusions: Contrast-enhanced ultrasound is useful for the assessment of vascularization of hydroxyapatite orbital implants and provides better visualization of the dynamic process than contrast-enhanced MRI.

Keywords: Contrast-enhanced magnetic resonance imaging; Contrast-enhanced ultrasound; Detection; Hydroxyapatite; Vascularization.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Contrast Media*
  • Female
  • Gadolinium DTPA
  • Humans
  • Hydroxyapatites*
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Neovascularization, Pathologic / diagnosis*
  • Orbit / blood supply*
  • Orbital Implants*
  • Phospholipids
  • Reproducibility of Results
  • Retrospective Studies
  • Sulfur Hexafluoride
  • Ultrasonography, Doppler, Transcranial / methods*

Substances

  • Contrast Media
  • Hydroxyapatites
  • Phospholipids
  • contrast agent BR1
  • Gadolinium DTPA
  • Sulfur Hexafluoride